Recently Featured

FDA Proposes Rating System to Enhance Quality Management Maturity in Drug Manufacturing

July 25, 2026
The FDA has proposed the development of a new rating system aimed at incentivizing drug manufacturers to achieve higher levels of Quality Management Maturity (QMM) within their facilities. This initiative reflects the agency’s ongoing commitment to improving pharmaceutical quality and ensuring that manufacturers adhere to stringent regulatory standards. In the context of increasing scrutiny on…

BridgeBio Secures Funding for Drug Launch; United Therapeutics Invests in Cell Therapy

July 25, 2026
BridgeBio Pharma has successfully secured substantial funding to advance the launch of its promising new drug, which targets genetic diseases. This financial backing is crucial as the company prepares for the competitive landscape of drug commercialization, particularly in the rare disease sector where innovative therapies are in high demand. The funding not only underscores investor…

QuantumCell commits $2.2bn on AlzeCure’s Alzheimer’s platform

July 25, 2026
QuantumCell has announced a significant investment of $2.2 billion in AlzeCure’s innovative platform targeting Alzheimer’s disease. This financial commitment underscores the growing urgency within the pharmaceutical industry to address the challenges posed by neurodegenerative disorders, particularly as the global population ages and the prevalence of Alzheimer’s increases. The lead product from AlzeCure’s platform has already…

BioPhorum Unites Regulators, Big Pharma and CDMOs to Accelerate Synthetic Molecule Innovation

July 25, 2026
LONDON – BioPhorum has announced the formation of the Synthetic Molecule Process Innovation Phorum, uniting an ecosystem of 20 leading organizations to urgently address the rapidly accelerating pace of innovation in the small molecule sector. This new initiative represents a significant portion of the small molecule supply chain, bringing together global pharmaceutical companies, including AstraZeneca,…

Ongoing Cases